Hudson Valley Investment Advisors Inc Adv buys $5,455,676 stake in Pfizer (PFE)

Pfizer (PFE) : Hudson Valley Investment Advisors Inc Adv scooped up 4,080 additional shares in Pfizer during the most recent quarter end , the firm said in a disclosure report filed with the SEC on Oct 11, 2016. The investment management firm now holds a total of 162,323 shares of Pfizer which is valued at $5,455,676.Pfizer makes up approximately 1.68% of Hudson Valley Investment Advisors Inc Adv’s portfolio.

Other Hedge Funds, Including , Canal Capital Management boosted its stake in PFE in the latest quarter, The investment management firm added 8,531 additional shares and now holds a total of 58,414 shares of Pfizer which is valued at $1,963,295. Pfizer makes up approx 1.83% of Canal Capital Management’s portfolio.Central Bank Trust Co reduced its stake in PFE by selling 956 shares or 1.72% in the most recent quarter. The Hedge Fund company now holds 54,753 shares of PFE which is valued at $1,837,511. Pfizer makes up approx 0.52% of Central Bank Trust Co’s portfolio.Curbstone Financial Management Corp reduced its stake in PFE by selling 850 shares or 1.48% in the most recent quarter. The Hedge Fund company now holds 56,645 shares of PFE which is valued at $1,920,266. Pfizer makes up approx 0.62% of Curbstone Financial Management Corp’s portfolio.Lynch Associatesin boosted its stake in PFE in the latest quarter, The investment management firm added 1,352 additional shares and now holds a total of 166,393 shares of Pfizer which is valued at $5,640,723. Pfizer makes up approx 2.49% of Lynch Associatesin’s portfolio.Cacti Asset Management reduced its stake in PFE by selling 175 shares or 0.23% in the most recent quarter. The Hedge Fund company now holds 75,100 shares of PFE which is valued at $2,545,890. Pfizer makes up approx 0.26% of Cacti Asset Management’s portfolio.

Pfizer closed down -0.48 points or -1.43% at $33.13 with 1,73,32,125 shares getting traded on Tuesday. Post opening the session at $33.56, the shares hit an intraday low of $32.94 and an intraday high of $33.57 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, Pfizer reported $0.64 EPS for the quarter, beating the analyst consensus estimate by $ 0.02 according to the earnings call on Aug 2, 2016. Analyst had a consensus of $0.62. The company had revenue of $13147.00 million for the quarter, compared to analysts expectations of $13013.24 million. The company’s revenue was up 10.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.56 EPS.

Investors should note that on Sep 22, 2016, Pfizer announced a cash dividend of $0.3000. The company’s management has announced Nov 9, 2016 as the ex-dividend date and fixed the record date on Nov 11, 2016. The payable date has been fixed on Dec 1, 2016.

Pfizer Inc. is a global biopharmaceutical company. The Company is engaged in discovering developing and manufacturing of healthcare products. Its products include Lyrica the Prevnar family of products Enbrel Celebrex Lipitor Viagra Zyvox Sutent EpiPen Toviaz Tygacil Rapamune Xalkori Inlyta Norvasc BeneFIX Genotropin and Enbrel among others. It operates in three segments: Global Innovative Pharmaceutical segment (GIP) Global Vaccines Oncology and Consumer Healthcare segment (VOC) and Global Established Pharmaceutical segment (GEP). GIP is focused on developing registering and commercializing medications in therapeutic areas such as inflammation cardiovascular/metabolic neuroscience and pain rare diseases and women’s/men’s health. VOC focuses on the development and commercialization of vaccines and products for oncology and consumer healthcare. GEP includes its sterile injectable products and bio similar development portfolio. Its subsidiary is Hospira Inc.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

Pfizer - Is it time to Sell?

Top Brokerage Firms are advising their investors on Pfizer. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.